» Articles » PMID: 24360764

Cardiometabolic Risk in Overweight Subjects with or Without Relative Fat-free Mass Deficiency: the Strong Heart Study

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: Sarcopenia is a condition mainly due to loss of fat-free mass (FFM) in elderly individuals. RFFMD, however, is also frequent in obese subjects due to abnormal body composition. Objective of this study was to evaluate the impact of relative fat-free mass deficiency (RFFMD) on cardiometabolic (CM) risk in obese normoglycemic individuals.

Methods And Results: Overweight/obese American Indians from the Strong Heart Study population, without diabetes and with FBG ≤ 110 mg/dL and with GFR >60 mg/mL/1.73 m(2) were selected for this analysis (n = 742). RFFMD was defined on the basis of a multivariable equation previously reported. Fasting glucose and 2 h-OGTT were measured together with urine albumin/creatinine excretion, laboratory and anthropometric parameters. In addition to lower FFM and greater adipose mass, participants with RFFMD had higher body mass index, waist circumference, C-reactive protein, fibrinogen, insulin resistance and urinary albumin/creatinine than participants with normal FFM (all p < 0.001); they also had a greater prevalence of hypertension, impaired glucose tolerance (IGT) or OGTT-diabetes than participants with normal FFM (all p < 0.003) and a near 2-fold greater probability of significant proteinuria (p < 0.01). RFFMD was more frequent in women than in men: significant sex-RFFMD interactions were found for BMI and waist circumference (both p < 0.0001).

Conclusions: RFFMD in overweight/obese normoglycemic individuals is associated with greater probability of hypertension, abnormalities of glucose tolerance and proteinuria. Assessment of RFFRMD might, therefore, help stratifying cardiometabolic risk among normoglycemic individuals with overweight/obesity.

Citing Articles

A comparison of principal component analysis, reduced-rank regression, and partial least-squares in the identification of dietary patterns associated with cardiometabolic risk factors in Iranian overweight and obese women.

Gholami F, Hajiheidari A, Barkhidarian B, Soveid N, Yekaninejad M, Karimi Z BMC Med Res Methodol. 2024; 24(1):215.

PMID: 39333898 PMC: 11428567. DOI: 10.1186/s12874-024-02298-z.


Obesity: the perfect storm for heart failure.

Lembo M, Strisciuglio T, Fonderico C, Mancusi C, Izzo R, Trimarco V ESC Heart Fail. 2024; 11(4):1841-1860.

PMID: 38491741 PMC: 11287355. DOI: 10.1002/ehf2.14641.


A New Approach Using BMI and FMI as Predictors of Cardio-Vascular Risk Factors among Mexican Young Adults.

Salinas-Mandujano R, Reynoso-Camacho R, Salgado L, Ramos-Gomez M, Perez-Ramirez I, Aguilar-Galarza A Eur J Investig Health Psychol Educ. 2023; 13(10):2063-2081.

PMID: 37887147 PMC: 10606082. DOI: 10.3390/ejihpe13100146.


Carotid Atherosclerosis Predicts Blood Pressure Control in Patients With Hypertension: The Campania Salute Network Registry.

Mancusi C, Manzi M, de Simone G, Morisco C, Lembo M, Pilato E J Am Heart Assoc. 2022; 11(5):e022345.

PMID: 35043688 PMC: 9075070. DOI: 10.1161/JAHA.121.022345.


Wrist circumference as a novel predictor of transition from metabolically healthy to unhealthy phenotype in overweight/obese adults: a gender-stratified 15.5-year follow-up.

Mousapour P, Barzin M, Valizadeh M, Mahdavi M, Hadaegh F, Azizi F BMC Public Health. 2021; 21(1):2276.

PMID: 34903195 PMC: 8670068. DOI: 10.1186/s12889-021-12371-7.


References
1.
de Simone G, Pasanisi F, Ferrara A, Roman M, Lee E, Contaldo F . Relative fat-free mass deficiency and left ventricular adaptation to obesity: the Strong Heart Study. Int J Cardiol. 2012; 168(2):729-33. PMC: 3606902. DOI: 10.1016/j.ijcard.2012.09.055. View

2.
Lee M, Chen R, Chang Y, Huang Y, Wahlqvist M . Physical function mitigates the adverse effects of being thin on mortality in a free-living older Taiwanese cohort. J Nutr Health Aging. 2012; 16(9):776-83. DOI: 10.1007/s12603-012-0379-3. View

3.
Devereux R, Alderman M . Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. Circulation. 1993; 88(4 Pt 1):1444-55. DOI: 10.1161/01.cir.88.4.1444. View

4.
. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res. 1998; 6 Suppl 2:51S-209S. View

5.
Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7):412-9. DOI: 10.1007/BF00280883. View